Concentrated fish oil (Lovaza®) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice

Experimental Biology and Medicine

Volumn 238, Issue 6, 2013, Pages 610-622

  Halade, Ganesh V ^a   Williams, Paul J ^a   Veigas, Jyothi M ^a   Barnes, Jeffrey L ^a   Fernandes, Gabriel ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Fish oil; inflammation; kidney disease; lifespan; lupus; survival

Indexed keywords

CATALASE; DOCOSAHEXAENOIC ACID; GLUTATHIONE PEROXIDASE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; OMEGA 3 ACID ETHYL ESTER; PLACEBO; SYNAPTOTAGMIN I; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; KIDNEY DISEASE; LIFE EXTENSION; LOW DRUG DOSE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

FISH OIL; INFLAMMATION; KIDNEY DISEASE; LIFESPAN; LUPUS; SURVIVAL;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; INFLAMMATION; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE;

EID: 84883824122     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213489485     Document Type: Article

References (51)

1. Rahman A,Isenberg DA.Systemic lupus erythematosus.N Engl J Med. 2008;358:929-39.
2. Kotzin BL.Systemic lupus erythematosus.Cell. 1996;85:303-6.
3. Symmons DP,Gabriel SE.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Nat Rev Rheumatol. 2011;7:399-408.
4. Helyer BJ,Howie JB.Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice.Nature. 1963;197:197-197.
5. Jacob N,Stohl W.Cytokine disturbances in systemic lupus erythematosus.Arthritis Res Ther. 2011;13:228-228.
6. Lin BF,Huang CH,Chiang BL,Jeng SJ.Dietary fat influences Ia antigen expression, cytokines and prostaglandin E2 production of immune cells in autoimmune-prone NZB x NZW F1 mice.Br J Nutr. 1996;75:711-22.
7. Halade GV,Rahman MM,Bhattacharya A,Barnes JL,Chandrasekar B,Fernandes G.Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice.J Immunol. 2010;184:5280-6.
8. Alexander NJ,Smythe NL,Jokinen MP.The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice.Am J Pathol. 1987;127:106-21.
9. Fernandes G,Venkatraman J,Khare A,Horbach GJ,Friedrichs W.Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids.Proc Soc Exp Biol Med. 1990;193:16-22.
10. Levy JA,Ibrahim AB,Shirai T,Ohta K,Nagasawa R,Yoshida H,Estes J,Gardner M.Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice.Proc Natl Acad Sci USA. 1982;79:1974-8.
11. Yumura W,Hattori S,Morrow WJ,Mayes DC,Levy JA,Shirai T.Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice.J Immunol. 1985;135:3864-8.
12. Erickson KL,Adams DA,Scibienski RJ.Dietary fatty acid modulation of murine B-cell responsiveness.J Nutr. 1986;116:1830-40.
13. Jyonouchi H,Sun S,Goodman D,Yokoyama H,Sato S.Dietary fatty acid modulates actions of nucleotides on humoral immune responses.Nutrition. 1995;11:437-43.
14. Yaqoob P,Calder PC.The effects of dietary lipid manipulation on the production of murine T cell-derived cytokines.Cytokine. 1995;7:548-53.
15. Pestka JJ.n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.Prostaglandins Leukot Essent Fatty Acids. 2010;82:251-8.
16. Aghdassi E,Ma DW,Morrison S,Hillyer LM,Clarke S,Gladman DD,Urowitz MB,Fortin PR.Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.JPEN J Parenter Enteral Nutr. 2011;35:198-208.
17. Nakamura N,Kumasaka R,Osawa H,Yamabe H,Shirato K,Fujita T,Murakami R,Shimada M,Nakamura M,Okumura K,Hamazaki K,Hamazaki T.Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis.In Vivo. 2005;19:879-82.
18. Fassett RG,Gobe GC,Peake JM,Coombes JS.Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.Am J Kidney Dis. 2010;56:728-42.
19. Pratt CM,Reiffel JA,Ellenbogen KA,Naccarelli GV,Kowey PR.Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study.Am Heart J. 2009;158:163-9 e1-3.
20. Lambert PH,Dixon FJ.Pathogenesis of the glomerulonephritis of NZB/W mice.J Exp Med. 1968;127:507-22.
21. Perry D,Sang A,Yin Y,Zheng YY,Morel L.Murine models of systemic lupus erythematosus.J Biomed Biotechnol. 2011;2011:271694-271694.
22. Jolly CA,Muthukumar A,Avula CP,Troyer D,Fernandes G.Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(1) mice fed a diet enriched with (n-3) fatty acids.J Nutr. 2001;131:2753-60.
23. Wang C,Li Q,Redden DT,Weindruch R,Allison DB.Statistical methods for testing effects on 'maximum lifespan'.Mech Ageing Dev. 2004;125:629-32.
24. Halade GV,Rahman MM,Williams PJ,Fernandes G.Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.J Nutr Biochem. 2011;22:459-69.
25. Halade GV,Rahman MM,Williams PJ,Fernandes G.High fat diet-induced animal model of age-associated obesity and osteoporosis.J Nutr Biochem. 2010;21:1162-9.
26. Chandrasekar B,Troyer DA,Venkatraman JT,Fernandes G.Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression.J Autoimmun. 1995;8:381-93.
27. Aringer M,Smolen JS.Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.Lupus. 2004;13:344-7.
28. Touma Z,Gladman DD,Ibanez D,Urowitz MB.Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.Rheumatology (Oxford). 2012;51:528-34.
29. Taysi S,Gul M,Sari RA,Akcay F,Bakan N.Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.Clin Chem Lab Med. 2002;40:684-8.
30. Enzler T,Bonizzi G,Silverman GJ,Widhopf GF,Anzelon-Mills A,Rickert RC,Karin M.Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.Immunity. 2006;25:403-15.
31. Gill JM,Quisel AM,Rocca PV,Walters DT.Diagnosis of systemic lupus erythematosus.Am Fam Physician. 2003;68:2179-86.
32. Chandrasekar B,Fernandes G.Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis.Biochem Biophys Res Commun. 1994;200:893-8.
33. Fernandes G.Dietary lipids and risk of autoimmune disease.Clin Immunol Immunopathol. 1994;72:193-7.
34. Venkatraman JT,Chandrasekar B,Kim JD,Fernandes G.Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice.Lipids. 1994;29:561-8.
35. Illei GG,Tackey E,Lapteva L,Lipsky PE.Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.Arthritis Rheum. 2004;50:2048-65.
36. Herrera-Esparza R,Barbosa-Cisneros O,Villalobos-Hurtado R,Avalos-Diaz E.Renal expression of IL-6 and TNFalpha genes in lupus nephritis.Lupus. 1998;7:154-8.
37. Maczynska I,Millo B,Ratajczak-Stefanska V,Maleszka R,Szych Z,Kurpisz M,Giedrys-Kalemba S.Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE).Immunol Lett. 2006;102:79-82.
38. Kalergis AM,Iruretagoyena MI,Barrientos MJ,Gonzalez PA,Herrada AA,Leiva ED,Gutiérrez MA,Riedal CA,Bueno SM,Jacobelli SH.Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus.Immunology. 2009;128:e306-14.
39. Sun D,Krishnan A,Zaman K,Lawrence R,Bhattacharya A,Fernandes G.Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.J Bone Miner Res. 2003;18:1206-16.
40. Weldon SM,Mullen AC,Loscher CE,Hurley LA,Roche HM.Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.J Nutr Biochem. 2007;18:250-8.
41. Caughey GE,James MJ,Proudman SM,Cleland LG.Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients.Complement Ther Med. 2010;18:171-4.
42. Dawczynski C,Schubert R,Hein G,Muller A,Eidner T,Vogelsang H,Basu S,Jahreis G.Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis.Br J Nutr. 2009;101:1517-26.
43. Miles EA,Calder PC.Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.Br J Nutr. 2012;107:S171-84.
44. Zaitone SA,Moustafa YM,Mosaad SM,El-Orabi NF.Effect of evening primrose oil and omega-3 polyunsaturated fatty acids on the cardiovascular risk of celecoxib in rats.J Cardiovasc Pharmacol. 2011;58:72-9.
45. Maradit-Kremers H,Nicola PJ,Crowson CS,Ballman KV,Gabriel SE.Cardiovascular death in rheumatoid arthritis: a population-based study.Arthritis Rheum. 2005;52:722-32.
46. Campbell RC,Batley M,Hammond A,Ibrahim F,Kingsley G,Scott DL.The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis.Clin Rheumatol. 2012;31:717-22.
47. Veigas JM,Williams PJ,Halade G,Rahman MM,Yoneda T,Fernandes G.Fish oil concentrate delays sensitivity to thermal nociception in mice.Pharmacol Res. 2011;63:377-82.
48. Bhattacharya A,Rahman M,Sun D,Fernandes G.Effect of fish oil on bone mineral density in aging C57BL/6 female mice.J Nutr Biochem. 2007;18:372-9.
49. Bhattacharya A,Rahman M,Banu J,Lawrence RA,McGuff HS,Garrett IR,Fischbach M,Fernandes G.Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids.J Am Coll Nutr. 2005;24:200-9.
50. Ryan MJ,McLemore GR,Hendrix ST.Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.Hypertension. 2006;48:988-93.
51. Halade GV,Jin YF,Lindsey ML.Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal.Cardiovasc Res. 2012;93:4-5.